These results revealed the role of ADCP of TAMs in cancer immunosuppression and suggested that simultaneous therapeutic antibodies and AIM2 inhibition of TAMs provide synergistic effects in cancer treatment [43]. The gene discussed is AIM2; the disease is cancer.